BioMAD - A Non-inferiority Study
Evaluation of the effectiveness of a new mandibular advancement device (BioMAD) in the treatment of obstructive sleep apnea.
Adult (≥ 18 years) with diagnosis of obstructive sleep apnea (AHI ≥ 5/h). [+4]
Predominant central sleep apnea. [+5]